Abstract

Quality Control and Physical and Chemical Stability of Hydrocortisone Oral Suspension: An Interlaboratory Study

Author(s): Santoveña A, Llabrés M, Fariña JB

Issue: Sep/Oct 2010 - Supporting Quality Pharmaceutical Compounding World Wide

Page(s): 430-435

Download in electronic PDF format for $75
  • Quality Control and Physical and Chemical Stability of Hydrocortisone Oral Suspension: An Interlaboratory Study Page 1
  • Quality Control and Physical and Chemical Stability of Hydrocortisone Oral Suspension: An Interlaboratory Study Page 2
  • Quality Control and Physical and Chemical Stability of Hydrocortisone Oral Suspension: An Interlaboratory Study Page 3
  • Quality Control and Physical and Chemical Stability of Hydrocortisone Oral Suspension: An Interlaboratory Study Page 4
  • Quality Control and Physical and Chemical Stability of Hydrocortisone Oral Suspension: An Interlaboratory Study Page 5
  • Quality Control and Physical and Chemical Stability of Hydrocortisone Oral Suspension: An Interlaboratory Study Page 6

Abstract

There were two objectives of this study, one of which was to ensure that different 1-mg/mL hydrocortisone oral suspensions that were prepared as compounded preparations in four accredited laboratories using the same standard operating procedure were in accordance with the general quality controls of these disperse systems and the specific requirements of the European Pharmacopeia, the Royal Spanish Pharmacopeia, and the United States Pharmacopeia. The other objective was to confirm the shelf-life of 90 days that was established for this type of compounded preparation. All the suspensions were in accordance with the organoleptic controls and with the theoretically calculated volume per unit of the preparation, but the amount of active ingredient per volume of the preparations were smaller than the theoretically expected. This result was attributed to the standard operating procedure because no significative differences between laboratories and days were detected, in which an excess of active ingredient is necessary to include in the process to ensure the declared dose. By high-performance liquid chromatography, it was possible to confirm the 90 days of stability of the drug at 5°C.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy
Title/Author
(Click for Abstract / Details / Purchase)
Sep/Oct 2010
Pg. 430-435
Sep/Oct 2021
Pg. 431-439
Jul/Aug 2017
Pg. 322-329
Jan/Feb 2018
Pg. 66-75
Sep/Oct 2014
Pg. 427-431
Sep/Oct 2003
Pg. 389-393
May/Jun 2007
Pg. 259-261
Author(s): Gupta Vishnu D
Jul/Aug 2021
Pg. 325
Author(s): Allen Loyd V Jr
Mar/Apr 2017
Pg. 160-163
Jan/Feb 2023
Pg. 72-77
May/Jun 2018
Pg. 240-246
Jan/Feb 2010
Pg. 76-77
Author(s): Gupta Vishnu D
Jul/Aug 2020
Pg. 327-336
Jan/Feb 2004
Pg. 10-14
Author(s): Preckshot John
Jan/Feb 2001
Pg. 9-12
Author(s): Schotik Debora
Sep/Oct 2015
Pg. 428-431
Author(s): Nahata Milap C
Nov/Dec 2021
Pg. 523-527
Jul/Aug 2020
Pg. 315
Author(s): Allen Loyd V Jr
Mar/Apr 2024
Pg. 151-155
Mar/Apr 2014
Pg. 169-174